Release date: 2024-07-09 17:23:07 Article From: Lucius Laos Recommended: 154
Sotorasib as a targeted therapeutic agent, is hailed as a milestone advancement in the medical field. As one of the pioneering small molecule inhibitors successfully targeting KRAS and entering human clinical development, Sotorasib demonstrates the ability to selectively and irreversibly inhibit the KRAS protein harboring the G12C mutation, thereby exhibiting immense potential in the treatment of malignant diseases such as NSCLC.
According to the label instructions, potential adverse effects associated with Sotorasib encompass but are not limited to the following points. Patients are advised to vigilantly monitor their physiological responses during the course of treatment and seek prompt medical attention should any discomfort arise.
Diarrhea is one of the most prevalent adverse effects associated with Sotorasib. Some patients may experience gastrointestinal symptoms, ranging from increased frequency of bowel movements in milder cases to more severe manifestations such as abdominal pain and dehydration.
Sotorasib may also induce musculoskeletal discomfort, which can manifest as either mild or severe. For mild discomfort, patients may attempt relief through methods such as rest and heat therapy; for severe discomfort, prompt medical attention should be sought.
Nausea is a common side effect of Sotorasib, which may potentially impact a patient's appetite and mood. To mitigate the occurrence of nausea, patients may consider consuming light and bland foods prior to medication administration.
Sotorasib, a prescription medication, should be strictly adhered to as directed by healthcare providers, and patients are advised against unauthorized alterations in dosage or administration. Prior to utilization, individuals should familiarize themselves with the prescribed dosage, contraindications, and potential side effects, thereby mitigating the risks associated with indiscriminate medication consumption.
Here is the recommended usage and dosage of Sotorasib. Patients should adhere to their physician's prescription and take the medication as directed and at the specified intervals.
The recommended dosage of Sotorasib is 960mg, to be taken orally once daily. This dosage should be adjusted based on the individual patient's specific circumstances and the advice of the physician. Patients should strictly adhere to the guidance of their healthcare provider and refrain from self-adjusting the medication dosage.
Patients should take Sotorasib at the same time each day, with or without food. It is important for patients to swallow the tablet whole and not chew, crush, or split it during administration.
[Warm tips] Patients undergoing treatment with Sotorasib should undergo regular examinations and evaluations by their physicians to stay abreast of their medical condition and medication efficacy. It is imperative for patients to maintain a healthy lifestyle and mindset during treatment, while actively adhering to their physician's therapeutic advice in order to expedite their recovery.
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:2012024-09-07
On November 14, 2024, the Committee for Medicinal Products for Human Use (CHMP) of the European Medi···【more】
Recommended:1582025-13-01
Recent advancements have reaffirmed the significance of liquid biopsy in the management of advanced ···【more】
Recommended:1562025-06-01
FDA Approves First Generic Version of Victoza (liraglutide injection)The U.S. Food and Drug Administ···【more】
Recommended:1712024-30-12
The new indication involves the treatment of adult patients with locally advanced, unresectable non-···【more】
Recommended:1612024-24-12
he U.S. Food and Drug Administration (FDA) has approved Crenessity (crinecerfont) for use in combina···【more】
Recommended:1462024-17-12
In the phase Ib/II multicenter pivotal FELIX study, the autologous 41BB-ζ anti-CD19 chimeric antigen···【more】
Recommended:1052024-13-12
On 25 July 2024, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHM···【more】
Recommended:2482024-26-08
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: